Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO)

17 filings reported holding SILO - Silo Pharma, Inc. - Common stock, par value $0.0001 per share as of Q4 2024.
Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 182,551 shares of 13,227,514 outstanding shares and own 1.4% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (37,500 shares), GEODE CAPITAL MANAGEMENT, LLC (34,948 shares), UBS Group AG (20,085 shares), VANGUARD GROUP INC (16,334 shares), XTX Topco Ltd (14,563 shares), STATE STREET CORP (12,500 shares), HRT FINANCIAL LP (11,448 shares), TWO SIGMA SECURITIES, LLC (11,375 shares), Virtu Financial LLC (10,430 shares), and Federation des caisses Desjardins du Quebec (6,000 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.